
Investing.com – Denmark stocks were higher after the close on Monday, as gains in the Consumer Goods, Healthcare and Real Estate sectors led shares higher.
At the close in Copenhagen, the OMX Copenhagen 20 rose 1.83% to hit a new all time high.
The best performers of the session on the OMX Copenhagen 20 were Novo Nordisk A/S Class B (CSE:NOVOb), which rose 3.09% or 26.30 points to trade at 877.20 at the close. Meanwhile, Novozymes A/S B (CSE:NZYMb) added 1.63% or 6.40 points to end at 398.60 and Coloplast A/S (CSE:COLOb) was up 1.57% or 14.40 points to 931.40 in late trade.
The worst performers of the session were Oersted AS (CSE:ORSTED), which fell 4.83% or 18.70 points to trade at 368.50 at the close. GN Store Nord (CSE:GN) declined 4.72% or 7.70 points to end at 155.50 and Genmab (CSE:GMAB) was down 3.12% or 63.00 points to 1,954.00.
Falling stocks outnumbered advancing ones on the Copenhagen Stock Exchange by 97 to 52 and 14 ended unchanged.
Shares in Novo Nordisk A/S Class B (CSE:NOVOb) rose to all time highs; rising 3.09% or 26.30 to 877.20. Shares in Novozymes A/S B (CSE:NZYMb) rose to 52-week highs; gaining 1.63% or 6.40 to 398.60.
Crude oil for April delivery was down 0.75% or 0.60 to $79.37 a barrel. Elsewhere in commodities trading, Brent oil for delivery in May fell 0.35% or 0.29 to hit $83.26 a barrel, while the April Gold Futures contract rose 1.26% or 26.45 to trade at $2,122.15 a troy ounce.
USD/DKK was down 0.18% to 6.86, while EUR/DKK unchanged 0.01% to 7.45.
The US Dollar Index Futures was down 0.06% at 103.74.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.